Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40656

EFHD1 Knockout NCI-H1975 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Carcinoma

The EFHD1 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population with disrupted EFHD1 gene in the NCI-H1975 lung adenocarcinoma cell line (EGFR L858R/T790M mutant). EFHD1 is a calcium-binding protein that regulates actin dynamics, cell adhesion, and apoptosis through interactions with cofilin and 14-3-3 proteins, impacting cancer cell migration and survival. This model is ideal for studying calcium signaling, cytoskeletal reorganization, apoptosis regulation, and EGFR inhibitor resistance. Applications include migration/invasion assays, Western blotting, immunofluorescence, and co-immunoprecipitation to investigate EFHD1-cofilin-14-3-3 pathways.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    NCI-H1975

    Sex of Donor

    Female

    Gene Name

    EFHD1

    Gene Identifier

    NCBI Gene ID 80303

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EFHD1 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population featuring disruption of the EFHD1 gene in the NCI-H1975 human lung adenocarcinoma cell line. This loss-of-function model consists of a heterogeneous pool of edited cells, maintaining the host line??s genetic background while eliminating EFHD1 expression. The polyclonal format avoids the selective pressure of single-cell cloning, providing a more physiologically relevant system that mirrors tumor cell heterogeneity and is well-suited for functional gene studies.

The host cell line NCI-H1975 is a widely utilized non-small cell lung cancer model derived from a female patient. These epithelial cells harbor activating EGFR L858R/T790M mutations, conferring constitutive kinase activity and resistance to first-generation tyrosine kinase inhibitors. NCI-H1975 is extensively applied to study EGFR-driven signal transduction, tumor progression, and mechanisms of drug resistance in lung adenocarcinoma.

EFHD1 is a calcium-binding EF-hand protein that regulates actin cytoskeleton organization and cell adhesion. It interacts with cofilin to modulate actin polymerization and binds 14-3-3 proteins, linking calcium signals to cytoskeletal dynamics. EFHD1 is activated by intracellular calcium and functions downstream of EGFR signaling, hypoxia, and TGF-??. It controls apoptotic signaling through BCL2 family proteins and caspase-3/7 activation, and influences FAK-mediated focal adhesion turnover.

In NCI-H1975 cells harboring EGFR L858R/T790M mutations, EFHD1 knockout provides a system to investigate calcium-binding protein contributions to EGFR inhibitor resistance, cytoskeletal reorganization, and apoptosis. This model is instrumental for studying how actin dynamics affect cell survival and invasion, potentially uncovering strategies to overcome drug resistance.

Applications include Transwell migration/invasion, wound healing, and Annexin V apoptosis assays. Western blotting of EFHD1, cofilin, cleaved caspases, and BCL2 members, immunofluorescence of F-actin and vinculin, calcium imaging, and co-immunoprecipitation are representative techniques. Used for research on cancer cell migration, calcium signaling, apoptosis, EGFR inhibitor resistance, and cytoskeletal dynamics. For further information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)